Parkinson Disease (2010-2023) - Market Insights, Epidemiology & Forecast - EU5 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Parkinson Disease - Market Insights, Epidemiology and Market Forecast - 2023 - EU5" drug pipelines to their offering.

The report provides an overview of the disease and global market size of the Parkinson's disease for the 7MM. It also includes global historical and forecasted epidemiological data for the diagnosed prevalent cases of Parkinson's disease from 2010-2023.

Parkinson's disease (PD) is a disorder caused by the malfunction and death of neurons. It is a chronic and progressive movement disorder which primarily affects neurons in substantia nigra area of the brain. Dopamine is usually responsible for the control and coordination process which is affected when the neuron malfunction and death occurs. As the disease progresses, the amount of dopamine produced in the brain decreases as a result the person is unable to control movement normally. This degenerative disorder affects the central nervous system.

Scope of the Report:

  • Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
  • Marketed information including available prescription drugs, its patent and exclusivity details.
  • The report also covers the detailed global historical and forecasted epidemiological data covering 7MM from 2010-2023.
  • It also provides Market size of Parkinson's disease for 7MM from 2010 and forecasted Market size to 2023.

Key Topics Covered:

  1. Report Introduction
  2. Parkinson's disease Market Overview at a Glance
  3. Total Market Size of Parkinson's disease for 7 MM in 2013-2023
  4. Total Market Share Distribution of Parkinson's disease for 7 MM in 2015
  5. Total Market Share Distribution of Parkinson's disease for 7 MM in 2023
  6. Overview
  7. Symptoms
  8. Pathophysiology
  9. Staging
  10. Diagnosis
  11. Treatment
  12. Epidemiology and Patient Population
  13. Diagnosed Cases of Parkinson's disease in United States
  14. Diagnosed Cases of Parkinson's disease in Germany
  15. Diagnosed Cases of Parkinson's disease in France
  16. Diagnosed Cases of Parkinson's disease in United Kingdom
  17. Diagnosed Cases of Parkinson's disease in Spain
  18. Diagnosed Cases of Parkinson's disease in Italy
  19. Diagnosed Cases of Parkinson's disease in Japan
  20. Top Marketed Drugs for Parkinson's disease
  21. Market Drivers
  22. Market Restraints
  23. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/bwjv7g/parkinson_disease

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs , Central Nervous System Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs , Central Nervous System Drugs